Issued Patents All Time
Showing 1–19 of 19 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10525046 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2020-01-07 |
| 10028944 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2018-07-24 |
| 9566271 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2017-02-14 |
| 9211289 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2015-12-15 |
| 8921393 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2014-12-30 |
| 8618130 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldan | 2013-12-31 |
| 8377959 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2013-02-19 |
| 8227487 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2012-07-24 |
| 8008323 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2011-08-30 |
| 7994193 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2011-08-09 |
| 7875632 | Selective serotonin receptor inverse agonists as therapeutics for disease | Robert E. Davis, Mark R. Brann | 2011-01-25 |
| 7863296 | Selective serotonin receptor inverse agonists as therapeutics for disease | Robert E. Davis, Mark R. Brann, Norman Nash | 2011-01-04 |
| 7820695 | Selective serotonin receptor inverse agonists as therapeutics for disease | Robert E. Davis, Mark R. Brann | 2010-10-26 |
| 7732462 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2010-06-08 |
| 7713995 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Norman Nash, Carl-Magnus A. Andersson, Allan K. Uldam | 2010-05-11 |
| 7659285 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2010-02-09 |
| 7601740 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam | 2009-10-13 |
| 7348140 | Clinical indications for genotyping polymorphic variants of G-protein coupled receptors | Mark R. Brann, Ethan S. Burstein, Jakob L. Hansen, Fabrice Piu, Andria Lee | 2008-03-25 |
| 6358698 | Methods of identifying inverse agonists of the serotonin 2A receptor | Mark R. Brann | 2002-03-19 |